Significance of blood analysis in hemophiliacs co-infected with human immunodeficiency virus and hepatitis viruses

Table 1 Blood viral load, immune and biochemical markers in hemophiliac patients mean ± SEM

	Hemophiliac patients
	HIV/HBV	HIV/HCV	HIV/HBV/HCV	HIV
No.	5	17	22	6
HIV viral load1	6.6 × 102 (< 50-105)	3.12 × 102 (< 50-105)	2.12 × 102 (< 50-105)	1.4 × 102 (< 50-104)
HBV viral load	Not detectable	Not applicable	Not detectable	Not applicable
HCV viral load	Not applicable	2.51 × 105 (< 103-107)	8.07 × 104 (103-107)	Not applicable
CD42 count	19.4 ± 3.4	21.56 ± 1.9	18.05 ± 1.7	25.17 ± 1.5
CD4/CD8	0.45 ± 0.13	0.46 ± 0.06	0.41 ± 0.06	0.63 ± 0.06
ALT (U/L)	18.2 ± 2	46 ± 8	47.6 ± 7.5
AST (U/L)	24.2 ± 2	44.8 ± 9	53.8 ± 9
TBIL (mol/L)	7.5 ± 1	10.4 ± 2	11.3 ± 1
ALP (U/L)	188.2 ± 42	214 ± 16	207.3 ± 15
γ-GT (U/L)	39.2 ± 17	103.5 ± 23	145.7 ± 25
A/G	1.41 ± 0.1	1.4 ± 0.07	1.7 ± 0.4
HA (ng/mL)	56.8 ± 12	73.8 ± 4.5	93 ± 15
CG (μg/dL)	183 ± 15	230 ± 65	257 ± 15
PC3 (μg/L)	108.3 ± 8	106.6 ± 3.2	107 ± 2.5
LN (ng/mL)	121.2 ± 19	111.7 ± 4	114 ± 3
IVC (ng/mL)	55.5 ± 22	46.5 ± 1.5	46 ± 1

¹Geometric mean viral loads and range of HIV RNA, HBV DNA and HCV RNA;

²Represented as percent of the total T cell (CD3+) population.